bioAffinity Stock (NASDAQ:BIAF)
Previous Close
$1.18
52W Range
$0.83 - $3.62
50D Avg
$1.32
200D Avg
$1.92
Market Cap
$15.47M
Avg Vol (3M)
$140.19K
Beta
3.12
Div Yield
-
BIAF Company Profile
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.